Carlo Visco, Alexander Tzankov, Zijun Y. Xu-Monette, Roberto N. Miranda, Yu Chuan Tai, Yan Li, Wei-min Liu, Emanuele S. G. d’Amore, Yong Li, Santiago Montes-Moreno, Karen Dybkær, April Chiu, Attilio Orazi, Youli Zu, Govind Bhagat, Huan-You Wang, Cherie H. Dunphy, Eric D. His, X. Frank Zhao, William WL. Choi, Xiaoying Zhao, J. Han van Krieken, Qin Huang, Weiyun Ai, Stacey O’Neill, Maurilio Ponzoni, Andres JM. Ferreri, Brad S. Kahl, Jane N. Winter, Ronald S. Go, Stephan Dirnhofer, Miguel A. Piris, Michael B. Møller, Lin Wu, L. Jeffrey Medeiros, Ken H. Young. Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study. Haematologica 2013;98(2):255-263; https://doi.org/10.3324/haematol.2012.066209.